Siglec-1-targeted nanobodies restrict HIV-1 transmission and infection of dendritic cells
ABSTRACT Human immunodeficiency virus 1 (HIV-1) remains a global health burden affecting over 39 million people worldwide, with approximately one million new infections occurring each year. Sexual transmission remains the predominant route of HIV-1 acquisition, during which the virus crosses mucosal barriers and intera...